| 18F -FDG | Fluorodeoxyglucose F18 |
| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| ALS-FRS-R | ALS functional rating scale revised |
| ASO | Antisense oligonucleotide |
| Bi | Behavioral impairment |
| Bci | Behavioral and cognitive impairment |
| BMI | Body mass index |
| C9orf72 | Chromosome 9 open reading frame 72 |
| Ci | Cognitive impairment |
| CEP | CarboxyEthylPyrole |
| CHIT1 | Chitotriosidase 1 |
| CNS | Central nervous system |
| CSA | Cross-sectional areas |
| CRP | C-reactive protein |
| CSF | Cerebrospinal fluid |
| DPRs | Dipeptide repeats |
| EEG | Electroencephalography |
| EVs | Extracellular vesicles |
| fALS | Familial ALS |
| FoxP3 | Forkhead box P3 |
| FUS | Fused in sarcoma |
| FTD | Frontotemporal dementia |
| FVC | Force vital capacity |
| HDL | High density lipoprotein |
| IL-6 | Interleukin-6 |
| LMN | Lower motor neurons |
| MND | Motor neuron disease |
| MMP1 | Matrix metalloproteinase 1 |
| MRI | Magnetic Resonance Imaging |
| MRN | Magnet resonance neurography |
| MUAP | Motor unit action potential |
| MUNIX | Motor unit number index |
| MUNE | Motor unit number estimation |
| NCT | Nuclear cytoplasmic transport |
| MPO | Myeloperoxidase |
| Nf | Neurofilaments |
| PBMC | Peripheral blood mononuclear cells |
| PET | Positron emission tomography |
| PFC | Prefrontal cortex |
| PLS | Primary lateral sclerosis |
| PMA | Progressive muscular atrophy |
| PNS | Peripheral nervous system |
| REE | Resting energy expenditure |
| ROI | Region of interest |
| sALS | Sporadic ALS |
| SOD1 | Superoxide dismutase 1 |
| TDP-43 | TAR DNA-binding protein 43 |
| TARDBP | TAR DNA-binding protein |
| UMN | Upper motor neurons |